Trials / Conditions / Ewing's Tumor Metastatic
Ewing's Tumor Metastatic
5 registered clinical trials studyying Ewing's Tumor Metastatic.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomi NCT03495921 | Gradalis, Inc. | Phase 3 |
| Unknown | Anlotinib and Irinotecan for Ewing Sarcoma NCT03416517 | Peking University People's Hospital | Phase 1 / Phase 2 |
| Unknown | A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma NCT02982486 | Assaf-Harofeh Medical Center | Phase 2 |
| Completed | Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma NCT02736565 | Gradalis, Inc. | Phase 1 |
| Temporarily Not Available | Expanded Access of Vigil in Solid Tumors NCT03842865 | Gradalis, Inc. | — |